HROW: Profitable, Cheap, Fast‑Growing Stock with Upside Catalysts
Just re-sharing this in case you missed my thoughts on $HROW last night... if you're a long term investor and looking for companies with asymmetric upside potential then this is a name that should definitely be on your watchlist. $HROW is not only profitable, cheap and growing fast but there are numerous catalysts on the horizon that could easily re-rate this stock to a much higher multiple. DFA. DYOR. **We have a position in $HROW at @FirstWaveFund
TIG Poised for Value Boost Amid Strategic Sale
I think we might see some action on $TIG soon. They have been pretty quiet so far, while normally the full financials would already have been published. $TIG is undergoing a strategic review, basically intending to unlock the large SOTP value...
Allergic to Construction: Costly Lessons From Founder-Led Firm
#MNGS my allergic reaction to the construction sector has arguably cost me dearly over the years…no more so than with this impressive founder led business https://t.co/ly4TY6lfDn
AIM Shares Show Bullish Momentum Near 820 Resistance
#AIM All Share small Up Candle, arguably a doji, but rising. Resistance 820, 837. Support 769, 750, 726. RSI 61.5 not high. 13/21 day EMAs Bullish. Top Bollinger Band 813. Midpoint Line 761. Bottom Band 710.
IONQ Short Interest at 22% Sparks 50% Rally
As of 31 March, the short position was equal to ~22% of $IONQ outstanding shares. The stock has rallied ~50% over the past couple of days, on watch for more short-covering in the days ahead.
ETF Dump, but I Stay Bullish on GRUSF
Thank god $TOKE is now done selling $GRUSF. The ETF sold 4 million shares in 30 days into a brutal drawdown right as the company's growth trajectory is taking off. As the largest shareholder in $GRUSF, I remain very bullish...
TOKE Liquidation Mistimed, Now Finally Concluding
The timing of the $TOKE liquidation could not have been worse. Selling illiquid cannabis stocks at the lows when we are on the cusp of federal reform was something I was against, but it wasn't my decision. At least the...
Small and Mid Caps Outpace Large Caps in Buybacks
BofA: small caps (in addition to mid caps) are now buying back more as a % of market cap than large caps https://t.co/ynbYTmLXzy
Quality Small Caps Win Long-Term, Junk Rallies Occasionally
We're in a late-cycle regime where quality still dominates—but with intermittent speculative rallies. Chart shows ratio of $IWM (Russell 2000, broader, lower-quality small caps) v $VIOO (S&P 600, higher-quality, profitable small caps). → When it falls, quality small caps outperform junky small...
OKLO’s Pipeline and Cash Boost Hope Despite Execution Risk
Someone on Reddit asked "is there any hope for $OKLO ?" It's up 9% today Quick fundamental check: - 14 GW signed customer pipeline (Switch, Meta, Equinix) - $1.23B cash with minimal debt - Board just got overhauled with nuclear/energy veterans - Pre-revenue but funded through...
Enhanced Ltd to Debut on NYSE May, Reshaping Sports
Enhanced Ltd is expected to start trading in early May under the ticker $ENHA on the New York Stock Exchange, subject to customary closing conditions. For those of you interested in participating early: if you buy SPAC trust shares $APAD...
BIRD Soars 800% After Bizarre Strategy Pivot
$BIRD up 800% today on the weirdest business strategy pivot I've ever seen... my condolences to anyone that gets caught holding this bag https://t.co/FwfmPn7on8
DGL Resumes Trading Amid Impairments and Resilient Earnings
By the way. Now that the financials are finally out (some expected impairments on non-core assets and pretty resilient earnings in tough markets), $DGL will resume trading. Let's see how they'll do tomorrow. I'm hoping on some massive tecnical selling pressure. Stink...
FDA Peptide Meeting Signals $100B Market Boom
I wish this FDA meeting to discuss peptides was happening a little sooner but I'm glad it's finally on the calendar so we don't have to keep guessing. Looks like they're going to start with 7 peptides (BPC-157, TB-500, KPV, Mots-C,...
IonQ Beats Milestones, Becomes Scalable Quantum Leader
IonQ's hitting its tech targets early, shifting from science project to scalable biz. Their trapped-ion quantum computers lead in quality. High risk, but a pure-play on the future. QuantumComputing
Avoid Shorting Low‑Float Recent DeSPACs, Especially AI
Idiots. Never, EVER short low float recent deSPACs. Particularly those with a (somewhat) AI angle these days $MRLN
Late Short Squeeze on IONQ, QBTS Prompted Quick Exit
I was short $IONQ and $QBTS from lower prices. I knew I was late to the short trade so fortunately they were extremely tiny positions. With the squeeze continuing at the open I covered them and quit the trade for...
Pagaya's AI Lending Grows; Bull Case Still Viable
Pagaya stock has been crushed, but the bull case isn't dead. Their AI lending network is still scaling with big partners. The goal? Reach profitability as macro headwinds ease. High-risk, high-reward bet. Fintech
CEO Slashes Salary Until Company Performance Improves
$DGL CEO taking a pay cut until performance improves. The guy doesn't need it. Still, would love to see this at pretty much every company I follow. https://t.co/bBgDpe00t2
Twist Stock Surges 60%: Fundamentals Drive Gains
$TWST has climbed over 60% since early Feb. post Trust the fundamentals...our superpower as investors is as simple as having access to earnings calls https://t.co/4pc8yK6fQE
Greenland Resources Valued at $2.5‑3B
At the current Molybdenum prices, Greenland Resources' $MOLY NPV sits around here (~$2.5-3.0bn) 👇 Market cap of $170m. https://t.co/q78aNaCpRO
BOWL Shows Strong Cash, Rising Dividend Despite Share Decline
#BOWL decent Update. Net Cash £26m. ShareScope has 11.8 falling to 11.1 and fwd Divvy 5% rising to 5.3%, BEFORE 6% rise today. Still interesting and good payout. I don't hold.
XPEL Poised for 100%+ Upside After Earnings Inflection
Multibagger pitch on $XPEL from @AltaFoxCapital - High quality share gainer in a secularly growing mkt - 3 years of heavy investment → earnings inflection ahead - EBIT margins set to 2x by FY28 - 100% upside on conservative EPS forecast - 250% if...
AGAE Settles Litigation, Surges on After‑Hours Volume
$AGAE - "Allied Gaming, Knighted Pastures settle litigation, end all outstanding matters" Over 17x relative volume here in after-hours on $AGAE, as it's testing the pivot over its daily 200MA... making it a definite watch for tomorrow. Will likely update my plan...
Considering Selling $VSNT as It
Now that it's becoming socially acceptable to own $VSNT, I'll probably start selling my position Here's the Einhorn note on it https://t.co/aCz9NT3GB6
High‑Risk $250 Short on $CAR: Not for Rookies
$CAR there's a $250 per share short trade on the back side. Patience and respect your stops. Not a trade for rookies.
IWM and VEU Surge Despite Weak Market Breadth
That doesn't look like great breadth, but $IWM and $VEU are soaring.. which matters https://t.co/PlPbLGi34t
Tiger Gold Doubles Down at Ceibal, Strong Buy
New pick @tigergoldcorp doubles down at Ceibal, with 2 rigs targeting a large-scale #gold system inside the broader 20k-meter program across the Quinchía project in Colombia’s Mid-Cauca belt. The corridor is already showing scale. Stock is a Strong Buy: https://t.co/znPTsmgY4L
IGV Bulls Rugged at Open, Buyers Hold Below
Man the $IGV bulls got rugged today on the open today and taking another leg down. Still a buyer below. Weird action tbh
XBI Dec $135 Calls Added After 120% Surge
Biotech (XBI) 10,000 December $135 calls bought adjusting the $120 calls from Oct. 8th that are up over 120%, a top Q1 group with M&A and approval upside
DTST's Record Profit Driven Entirely by One‑time Gain
$DTST... highlighting record net income in their earning press release when it all came from a gain. This is the stuff that gives microcaps a bad name (well one of them 🤣)... Makes sure to always read press releases beyond...
Capstone Poised for Multi‑bagger as Growth Accelerates
I think it might soon be $CGEH time again. Def no chartist here, but I like what I'm seeing. Results are backing the story. Continued good revenue and profitability growth. Capstone is getting more and more traction. This will feed momentum...
Rapid $50k Analysis
See someone did the math overnight on $50k tin for what the metrics are on AlphaMoon $AFM.V
IRDM Soars Over 100% on GSAT Deal
$IRDM sympathy boost from GSAT deal These May 30's up over 100% now and April 25's way more https://t.co/YjtlZfaXyk
Acquisitions and Partnerships Spark Sharp Stock Gains
$CRDO Credo Technology DustPhotonics 인수 발표, 광통신 확장 기대에 급등 - DustPhotonics 인수 발표 후 주가 약 20% 급등 - 인수 대가, 현금 7.5억달러와 Credo 주식 92만주 - AI 네트워킹 핵심 광트랜시버 기술 확대 기대 반영 $BE Bloom Energy Oracle 협력 확대, 데이터센터 전력 수요 기대에...
Tonies Defies Odds with Strong Revenue and Margin Growth
Tonies $TNIE remains such a weird company. After listing I honestly never thought they'd still be doing this well. Euro SPAC, weird product, hype potential, etc. Ok the share price is barely back at 10, but operationally performance has been quite decent: >...
TVTX Surges 45% After FDA Approval, Long Calls Lead
$TVTX jumps 45% on FDA approval, always liked this one, continues to work 5K Apr. 32.5 long calls leads the way https://t.co/g7Ga8FIJve
Half of Microcaps Survive, Few Beat S&P
Always fascinating to see the base rates of microcap success. A multi-part "Hendrik Bessembinder" report on microcaps brewing here.. After 10 years: 51% of microcaps still exist in the dataset 24% returned > 0 9% returned > S&P 500 3% returned 10x or more H/T @RTelford_invest
ITRK Jumps 11% Amid Strategic Split Review
#ITRK strong start to year and reiterates guidance. Launch of Strategic Review which may split the company up. ShareScope has fwd p/e 14.4 falling to 13.3 and fwd Divvy 4.5% rising to 4.8%, BEFORE 11% jump today. Very interesting business....
CRPR Edges Out Danger Zone, EBITDA Question
#CRPR good to see them inching out of the danger zone …not sure EBITDA is the correct measure in an asset heavy indebted business but I’m old fashioned like that https://t.co/ioDi7MeZfx
Acquisition‑driven Growth Often Ends with Surprising Exits
#ABDP Dr Routh left a suprise https://t.co/ldjsQSeRcK Acquisition driven growth often ends this way https://t.co/2cHFTHOvPH
WM Senibong IPO: Bet on Singapore’s Land Scarcity
The upcoming RM500 million IPO of WM Senibong isn't a signal of Malaysia's domestic property strength—it's a massive, coordinated bet on Singapore's shrinking land space. While the headlines focus on the target valuation of more than RM2 billion, there's a...
Seeking Bigger Omai Deal over Braskem, Requires Corp Dev
Sold this to size up Omai $OMG.v Not a reflection on Braskem but just really like the Omai project + valuation and feeling undersized there Needs some Corp dev and IR savy but that’s fixable
Rezolve Secures $232M Deal, Targets $360M Guidance
Macro: AI-commerce consolidation. Rezolve (RZLV) investor call; $232M contracted for 2026, $360M guidance vs Commerce.com's weak base. Risk: approvals & execution. Trading insight: consider long RZLV pre-call. 📞 — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov
FMKT Gains 1.8% as Deregulation ETF Leads
Today's close: The Free Markets ETF ( $FMKT ) at $21.27, climbing 1.79% since yesterday. Looking for opportunity in regulatory change? $FMKT is the pioneer ETF exclusively investing in companies we believe are positioned to benefit from deregulation. https://t.co/oO1zGkqC4s
Factor Goes Long on Small‑Cap ETFs, Targets Higher Gains
The children have entered the parade. The Factor company account is long in this space. Much higher targets in mind. $SCHA $IWM Stay tuned. Follow the parade here: https://t.co/gDeM5nTRIY https://t.co/6CxE0wC8OT
OKLO Surges Above 10/21 MA, Short Float Highlights
$OKLO back over 10/21 ma and the gap up from last week test and bounce. Note the short float. https://t.co/shm0yFO6wS
FGFH's 9% ROE Boosts Stock, Yet Remains Undervalued
Today’s state of community bank stocks. $FGFH printed a 9% ROE quarter today. The stock is up 44% in the last year and still trades below book value. Perhaps justified as the improved results still don’t earn independence. https://t.co/1Uj2Cz2dR2 https://t.co/EFXtj5yKpY
Deal Undervalues Secure, Shareholders Lose Billions
If this deal goes through as written, it's an incredibly disappointing outcome for $SES.TO shareholders. Our base case was C$34/share using conservative assumptions. Instead, shareholders are being asked to sell a scarce, high-quality waste infrastructure asset for C$24.75/share, mostly in GFL...
Off‑the‑Shelf CAR‑T Shows Promise Delaying Lymphoma Relapse
Allogene data suggest ‘off-the-shelf’ CAR-T could delay relapse in lymphoma https://t.co/UrSNYpQFqB by @gwendolynawu $ALLO + 25%